Home/ Supplements/ Vitamin K/ SP Detox Balance

SP Detox Balance

product on market Powder SP Standard Process Safety: 90/100
90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 21% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The product contains basic macronutrients and Vitamin K1, which is essential for blood coagulation and bone health. Research providing evidence for these components is strong, though the overall evidence coverage for this specific formulation is very limited. The profile is generally considered safe for consumption.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Contains proprietary blend — exact ingredient amounts not disclosed

Label

Product Label

Label for SP Detox Balance
Open Full PDF View on NIH DSLD →
Details

Label Data

37 Gram(s)
Serving Size
21
Servings
Other Combinations
Product Type
21%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
160 Calorie(s)
Total Fat
5 Gram(s) (6% DV)
Total Carbohydrates
11 Gram(s) (4% DV)
Protein
17 Gram(s) (34% DV)
4 mcg (3% DV)
Market median: 0.1mg (347 products) 275 studies (A:9, B:175)
70 mg (13% DV)
Within RDA (0.1× RDA) 38 studies (A:1, B:7)
Calcium
70 mg (5% DV)
Iron
4 mg (22% DV)
70 mg (17% DV)
Within RDA (0.2× RDA) 316 studies (A:8, B:159)
Sodium
190 mg (8% DV)
Potassium
230 mg (5% DV)
1300 mg
Market median: 500.0mg (143 products)
Glycine
600 mg
850 mg
Market median: 17.4mg (161 products)
1600 mg
Market median: 17.4mg (161 products)
300 mg
Market median: 500.0mg (193 products) 7 studies — no high-quality reviews
L-Valine
900 mg
600 mg
Market median: 5.0mg (298 products) 705 studies (A:5, B:123)
Proprietary Blend
34.4 Gram(s)

Other Ingredients

Creatine L-Leucine Xanthan Gum L-Isoleucine L-Valine DL-Methionine Monk Fruit Extract Choline Bitartrate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: Two heaping scoops in 10-12 ounces water, one to three servings per day, or as directed.

Warnings & Precautions

Warning: This product contains naturally occurring Vitamin K1.

If you are taking blood-thinning medicines, are pregnant, nursing, or have been directed to eat a diet low in oxalates, please consult with your health care professional before taking this product.

Not intended for long-term use unless otherwise directed by your health care professional.

Keep out of reach of children.

Formulation Notes

Whole body detoxification

Vegan

GF (Gluten free)

Additional Information

Store in a cool, dry place once opened.

Vegan

Whole Food Supplements Since 1929

Metadata

Product Details

UPC / SKU8 12122 01688 9
DSLD Entry Date2025-09-25
Product TypeOther Combinations
FormPowder
DSLD ID340373
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.